1Naz RK, Dabir P. Peptide vaccines against cancer, infec- tious diseases, and conception [ J ]. Front Biosci, 2007, 12:1833.
2Kawakami Y, Cancer treatment by comprehensive regula- tion of anti-tumor immune network [ J ]. Nihon Rinsho, 2010, 68(6) :1094.
3Khazaie K, Bonertz A, Beckhove P. Current developments with peptide-based human tumor vaccines [ J ]. Curr Opin Oncol, 2009, 21(6):524.
4Beck A, Klinguer-Hamour C, Bussat MC, et al. Peptides as tools and drugs for immunotherapies [ J ]. J Pept Sci, 2007, 13(9) :588.
5Caballero OL, Chen YT. Cancer/testis (CT) antigens: potential targets for immunotherapy [ J ]. Cancer Sci, 2009, 100(11) :2014.
6Ahneida LG, Sakabe N J, deOliveira AR, et al. CTdata- base : a knowledge-base of high-throughput and curated da- ta on cancer-testis antigens[ J ]. Nucleic Acids Res, 2009, 37 ( Database issue) : D816.
7Bao L, Dunham K, Lucas K. MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to fa- cilitate cytotoxic T lymphocyte-mediated tumor cell killing [ J ]. Cancer Immunol Immunother ,2011 May 28 [ Epub a- head of print ].
8Reuschenbach M, Waterboer T, Wallin KL, et al. Char- acterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-as-sociated cancers[J]. Int J Cancer, 2008, 123(11) :2626.
9Gardiner J, Overall R, Marc J. Putative Arabidopsis hom- ologues of metazoan coiled-coil cytoskeletal proteins [ J ]. Cell Biol Int, 2011,35(8) :767.
10Sahoo R, Babu VC, Harini VV, et al. Her-2/neu overex- pression due to polysomy 17 in breast cancer: molecular testing to guide therapeutic options[ J]. Onkologie, 2011, 34(7) :356.
3Amadori D, Milandri C, Comella G, et al. A phase 1/17 trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer[ J ]. Eur J Cancer,2011, 1 0.
4Melief CJ. Van der Burg SH. lmmunotherapy of established (per) malignant disease by synthetic long peptide vaccines[ J]. Nat Rev Cartcer,2008,8(5 ) :351.
5Van der Bruggen P, Traversari C, Chomez P, et al. A geneencod- ing an antigen recognized by cytolytic T lymphoeytes on a human melanoma [J ]. Science, 1991,254 ( 5038 ) : 1643.
6Sahoo R, Babu VC, Harini VV, et al. Her-2/neu overexpression due to polysomy 17 in breast cancer: molecular testing to guide therapeutic options [ J] Onkologie,2011,34 (7) : 356.
7Wang H,Su X,Zhang P,et al. Recombinant heat shock protein 65 carrying PADRE and HBV epitopes activates dendritic cells and elicits HBV-specific CTL responses [ J ]. Vaccine, 2011, 29 (12) :2328.
10Young-Ik Son, Shin-ichi Egawa, Tomohide Tatsumi, et al. A novelbulk-culture method for generating mature dendritic cells from mouse bone marrow cells [J]. J Immunol Meth,2002,262,145.
